Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Abigail Heher"'
Autor:
Pedro Costa-Pinheiro, Abigail Heher, Michael H. Raymond, Kasey Jividen, Jeremy JP. Shaw, Bryce M. Paschal, Susan J. Walker, Todd E. Fox, Mark Kester
Publikováno v:
iScience, Vol 23, Iss 12, Pp 101855- (2020)
Summary: Anti-androgens are a common therapy in prostate cancer (PCa) targeting androgen receptor (AR) signaling. However, these therapies fail due to selection of highly aggressive AR-negative cancer cells that have no therapeutic options available.
Externí odkaz:
https://doaj.org/article/e195566108ee4580971a934e8bc4e80d
Autor:
Michael H. Raymond, Jeremy Jp. Shaw, Pedro Costa-Pinheiro, Bryce M. Paschal, Abigail Heher, Kasey Jividen, Todd E. Fox, Mark Kester, Susan J. Walker
Publikováno v:
iScience, Vol 23, Iss 12, Pp 101855-(2020)
iScience
iScience
Summary Anti-androgens are a common therapy in prostate cancer (PCa) targeting androgen receptor (AR) signaling. However, these therapies fail due to selection of highly aggressive AR-negative cancer cells that have no therapeutic options available.
Autor:
Kasey Jividen, Todd E. Fox, Abigail Heher, Mark Kester, Pedro Costa-Pinheiro, Michael H. Raymond
Publikováno v:
Cancer Research. 80:2079-2079
Prostate cancer (PCa) is estimated to account for 20% of newly diagnosed cancers and 10% of cancer-related deaths in US men during 2019. Prostate is a hormone-responsive gland that depends on male hormones, such as testosterone, for its normal growth